TriSalus Life Sciences, Inc. Conversion of Stock, Shares Issued
TriSalus Life Sciences, Inc. (TLSI) reported Conversion of Stock, Shares Issued of 1 shares for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-02.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:ConversionOfStockSharesIssued1 · last filed 2023-08-02
- TriSalus Life Sciences, Inc. conversion of stock, shares issued for the quarter ending 2023-06-30 was 0.00 shares.
- TriSalus Life Sciences, Inc. conversion of stock, shares issued for the quarter ending 2023-03-31 was 1.00 shares.
- TriSalus Life Sciences, Inc. conversion of stock, shares issued for the quarter ending 2022-09-30 was 0.00 shares.
| Period end | Conversion of Stock, Shares Issued 3 month | Conversion of Stock, Shares Issued 6 month | Conversion of Stock, Shares Issued 9 month |
|---|---|---|---|
| 2023-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | 1.00 shares 10-Q · filed 2023-08-02 | |
| 2023-03-31 | 1.00 shares 10-Q · filed 2023-05-12 | ||
| 2022-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | 1.00 shares 10-Q · filed 2022-11-10 | |
| 2022-06-30 | 1.00 shares 10-Q · filed 2022-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |